Verastem

Recent news

• Rating change
  BTIG Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $18
  Market Newswire · 2026/5/8
• Rating change
  Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2026/4/16
• Rating change
  Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14
  Market Newswire · 2026/5/13
• Company notice
  Verastem: Verastem, Inc. - Reverse Split Option Symbol: VSTM New Symbol: VSTM1
  OCC · 2023/5/31
• Rating change
  Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $13
  Market Newswire · 2026/8/11
• Rating change
  H.C. Wainwright Keeps Their Buy Rating on Verastem (VSTM)
  TipRanks · 2026/5/8
• Rating change
  Verastem (VSTM) Receives a Buy From B. Riley Securities
  TipRanks · 2026/5/22
• RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $14
  Market Newswire · 2026/9/18
• Rating change
  A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $12 to $18
  Market Newswire · 2026/8/7
• Rating change
  BTIG Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $19
  Market Newswire · 2026/4/21
• BTIG Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $18
  Market Newswire · 2026/10/5
• RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14
  Market Newswire · 2026/7/7
• Rating change
  Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $14
  Market Newswire · 2026/6/18
• Rating change
  Analysts Offer Insights on Healthcare Companies: Atai Beckley N.V. (ATAI), Madrigal Pharmaceuticals (MDGL) and Verastem (VSTM)
  TipRanks · 2026/6/24
• Rating change
  H.C. Wainwright Sticks to Their Buy Rating for Verastem (VSTM)
  TipRanks · 2026/5/27
• H.C. Wainwright Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $18
  Market Newswire · 2026/10/5
• Rating change
  RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $15
  Market Newswire · 2026/5/8
• Wolfe Research Maintains Verastem(VSTM.US) With Buy Rating
  Market Newswire · 2026/9/17
• Rating change
  A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $14 to $18
  Market Newswire · 2026/6/25
• Rating change
  A Quick Look at Today's Ratings for Verastem(VSTM.US), With a Forecast Between $8 to $18
  Market Newswire · 2026/6/24

Headlines are aggregated automatically and are not independently verified or edited by our team.